Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

An Adenosine-Mediated Glial-Neuronal Circuit for Homeostatic Sleep.

Bjorness TE, Dale N, Mettlach G, Sonneborn A, Sahin B, Fienberg AA, Yanagisawa M, Bibb JA, Greene RW.

J Neurosci. 2016 Mar 30;36(13):3709-21. doi: 10.1523/JNEUROSCI.3906-15.2016.

2.

Methylphenidate restores novel object recognition in DARPP-32 knockout mice.

Heyser CJ, McNaughton CH, Vishnevetsky D, Fienberg AA.

Behav Brain Res. 2013 Sep 15;253:266-73. doi: 10.1016/j.bbr.2013.07.031. Epub 2013 Jul 29.

PMID:
23906769
3.

Forebrain overexpression of CK1delta leads to down-regulation of dopamine receptors and altered locomotor activity reminiscent of ADHD.

Zhou M, Rebholz H, Brocia C, Warner-Schmidt JL, Fienberg AA, Nairn AC, Greengard P, Flajolet M.

Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4401-6. doi: 10.1073/pnas.0915173107. Epub 2010 Feb 9.

4.

Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signalling.

O'Sullivan GJ, Dunleavy M, Hakansson K, Clementi M, Kinsella A, Croke DT, Drago J, Fienberg AA, Greengard P, Sibley DR, Fisone G, Henshall DC, Waddington JL.

Neuropharmacology. 2008 Jun;54(7):1051-61. doi: 10.1016/j.neuropharm.2008.02.011. Epub 2008 Feb 21.

5.
6.

Disruption of orofacial movement topographies in congenic mutants with dopamine D5 but not D4 receptor or DARPP-32 transduction 'knockout'.

Tomiyama K, Makihara Y, Yamamoto H, O'Sullivan G, Nally RE, Tighe O, Kinsella A, Fienberg AA, Grandy DK, Sibley DR, Croke DT, Koshikawa N, Waddington JL.

Eur Neuropsychopharmacol. 2006 Aug;16(6):437-45. Epub 2006 Jan 18.

PMID:
16413758
7.

Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons.

Andersson M, Usiello A, Borgkvist A, Pozzi L, Dominguez C, Fienberg AA, Svenningsson P, Fredholm BB, Borrelli E, Greengard P, Fisone G.

J Neurosci. 2005 Sep 14;25(37):8432-8.

8.

Phosphorylation of DARPP-32 at Threonine-34 is required for cocaine action.

Zachariou V, Sgambato-Faure V, Sasaki T, Svenningsson P, Berton O, Fienberg AA, Nairn AC, Greengard P, Nestler EJ.

Neuropsychopharmacology. 2006 Mar;31(3):555-62.

9.

DARPP-32 phosphorylation opposes the behavioral effects of nicotine.

Zhu H, Lee M, Guan F, Agatsuma S, Scott D, Fabrizio K, Fienberg AA, Hiroi N.

Biol Psychiatry. 2005 Dec 15;58(12):981-9. Epub 2005 Aug 9.

PMID:
16084497
10.

A network of control mediated by regulator of calcium/calmodulin-dependent signaling.

Rakhilin SV, Olson PA, Nishi A, Starkova NN, Fienberg AA, Nairn AC, Surmeier DJ, Greengard P.

Science. 2004 Oct 22;306(5696):698-701.

11.

Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties.

Ito D, Walker JR, Thompson CS, Moroz I, Lin W, Veselits ML, Hakim AM, Fienberg AA, Thinakaran G.

Mol Cell Biol. 2004 Nov;24(21):9456-69.

12.

Ovarian function and morphology after deletion of the DARPP-32 gene in mice.

Mayerhofer A, Fritz S, Mani S, Rajendra Kumar T, Thalhammer A, Ingrassia P, Fienberg AA, Greengard P.

Exp Clin Endocrinol Diabetes. 2004 Sep;112(8):451-7.

PMID:
15372366
13.

Molecular characterization of recombinant mouse adenosine kinase and evaluation as a target for protein phosphorylation.

Sahin B, Kansy JW, Nairn AC, Spychala J, Ealick SE, Fienberg AA, Greene RW, Bibb JA.

Eur J Biochem. 2004 Sep;271(17):3547-55.

15.

Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32.

Dunah AW, Sirianni AC, Fienberg AA, Bastia E, Schwarzschild MA, Standaert DG.

Mol Pharmacol. 2004 Jan;65(1):121-9.

PMID:
14722243
16.

Diverse psychotomimetics act through a common signaling pathway.

Svenningsson P, Tzavara ET, Carruthers R, Rachleff I, Wattler S, Nehls M, McKinzie DL, Fienberg AA, Nomikos GG, Greengard P.

Science. 2003 Nov 21;302(5649):1412-5.

17.

Regulation of AMPA receptor dephosphorylation by glutamate receptor agonists.

Snyder GL, Galdi S, Fienberg AA, Allen P, Nairn AC, Greengard P.

Neuropharmacology. 2003 Nov;45(6):703-13.

PMID:
14529709
18.

Topographical Assessment of Ethological and Dopamine Receptor Agonist-Induced Behavioral Phenotype in Mutants with Congenic DARPP-32 'Knockout'.

Nally RE, McNamara FN, Clifford JJ, Kinsella A, Tighe O, Croke DT, Fienberg AA, Greengard P, Waddington JL.

Neuropsychopharmacology. 2003 Dec;28(12):2055-63.

19.

Dopamine modulation of membrane excitability in striatal spiny neurons is altered in DARPP-32 knockout mice.

Onn SP, Fienberg AA, Grace AA.

J Pharmacol Exp Ther. 2003 Sep;306(3):870-9. Epub 2003 Jun 12.

PMID:
12805477
20.

Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32.

Flores-Hernández J, Cepeda C, Hernández-Echeagaray E, Calvert CR, Jokel ES, Fienberg AA, Greengard P, Levine MS.

J Neurophysiol. 2002 Dec;88(6):3010-20.

21.

Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine.

Lindskog M, Svenningsson P, Pozzi L, Kim Y, Fienberg AA, Bibb JA, Fredholm BB, Nairn AC, Greengard P, Fisone G.

Nature. 2002 Aug 15;418(6899):774-8.

PMID:
12181566
22.

DARPP-32 and regulation of the ethanol sensitivity of NMDA receptors in the nucleus accumbens.

Maldve RE, Zhang TA, Ferrani-Kile K, Schreiber SS, Lippmann MJ, Snyder GL, Fienberg AA, Leslie SW, Gonzales RA, Morrisett RA.

Nat Neurosci. 2002 Jul;5(7):641-8.

PMID:
12068305
23.

Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors DARPP 32 or Inhibitor 1.

Zachariou V, Benoit-Marand M, Allen PB, Ingrassia P, Fienberg AA, Gonon F, Greengard P, Picciotto MR.

Biol Psychiatry. 2002 Apr 15;51(8):612-20.

PMID:
11955461
24.

DARPP-32 mediates serotonergic neurotransmission in the forebrain.

Svenningsson P, Tzavara ET, Liu F, Fienberg AA, Nomikos GG, Greengard P.

Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3188-93.

25.

Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac).

Svenningsson P, Tzavara ET, Witkin JM, Fienberg AA, Nomikos GG, Greengard P.

Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3182-7.

26.

Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum.

Hervé D, Le Moine C, Corvol JC, Belluscio L, Ledent C, Fienberg AA, Jaber M, Studler JM, Girault JA.

J Neurosci. 2001 Jun 15;21(12):4390-9.

27.

Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia.

Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA.

Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4746-51.

28.

Motivational effects of ethanol in DARPP-32 knock-out mice.

Risinger FO, Freeman PA, Greengard P, Fienberg AA.

J Neurosci. 2001 Jan 1;21(1):340-8.

29.

Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity.

Calabresi P, Gubellini P, Centonze D, Picconi B, Bernardi G, Chergui K, Svenningsson P, Fienberg AA, Greengard P.

J Neurosci. 2000 Nov 15;20(22):8443-51.

30.

Drugs of abuse modulate the phosphorylation of ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in the basal ganglia.

Caporaso GL, Bibb JA, Snyder GL, Valle C, Rakhilin S, Fienberg AA, Hemmings HC, Nairn AC, Greengard P.

Neuropharmacology. 2000 Jul 10;39(9):1637-44.

PMID:
10854908
31.

Dopamine D(1) receptor-induced gene transcription is modulated by DARPP-32.

Svenningsson P, Fienberg AA, Allen PB, Moine CL, Lindskog M, Fisone G, Greengard P, Fredholm BB.

J Neurochem. 2000 Jul;75(1):248-57.

32.

Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo.

Snyder GL, Allen PB, Fienberg AA, Valle CG, Huganir RL, Nairn AC, Greengard P.

J Neurosci. 2000 Jun 15;20(12):4480-8.

33.

DARPP-32 knockout mice exhibit impaired reversal learning in a discriminated operant task.

Heyser CJ, Fienberg AA, Greengard P, Gold LH.

Brain Res. 2000 Jun 9;867(1-2):122-30.

PMID:
10837805
34.

D(1) dopamine receptor activation reduces GABA(A) receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade.

Flores-Hernandez J, Hernandez S, Snyder GL, Yan Z, Fienberg AA, Moss SJ, Greengard P, Surmeier DJ.

J Neurophysiol. 2000 May;83(5):2996-3004.

35.

Synapsins as mediators of BDNF-enhanced neurotransmitter release.

Jovanovic JN, Czernik AJ, Fienberg AA, Greengard P, Sihra TS.

Nat Neurosci. 2000 Apr;3(4):323-9.

PMID:
10725920
36.

The DARPP-32 knockout mouse.

Fienberg AA, Greengard P.

Brain Res Brain Res Rev. 2000 Mar;31(2-3):313-9. Review. No abstract available.

PMID:
10719158
37.

Requirement for DARPP-32 in progesterone-facilitated sexual receptivity in female rats and mice.

Mani SK, Fienberg AA, O'Callaghan JP, Snyder GL, Allen PB, Dash PK, Moore AN, Mitchell AJ, Bibb J, Greengard P, O'Malley BW.

Science. 2000 Feb 11;287(5455):1053-6.

38.

Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.

Bibb JA, Snyder GL, Nishi A, Yan Z, Meijer L, Fienberg AA, Tsai LH, Kwon YT, Girault JA, Czernik AJ, Huganir RL, Hemmings HC Jr, Nairn AC, Greengard P.

Nature. 1999 Dec 9;402(6762):669-71.

PMID:
10604473
39.

Effects of chronic 'Binge' cocaine administration on plasma ACTH and corticosterone levels in mice deficient in DARPP-32.

Zhou Y, Schlussman SD, Ho A, Spangler R, Fienberg AA, Greengard P, Kreek MJ.

Neuroendocrinology. 1999 Sep;70(3):196-9.

PMID:
10516482
40.

D(2) dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons.

Yan Z, Feng J, Fienberg AA, Greengard P.

Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11607-12.

41.

Inhibitor-1 is not required for the activation of glycogen synthase by insulin in skeletal muscle.

Scrimgeour AG, Allen PB, Fienberg AA, Greengard P, Lawrence JC Jr.

J Biol Chem. 1999 Jul 23;274(30):20949-52.

42.

Requirement for DARPP-32 in mediating effect of dopamine D2 receptor activation.

Nishi A, Snyder GL, Fienberg AA, Fisone G, Aperia A, Nairn AC, Greengard P.

Eur J Neurosci. 1999 Jul;11(7):2589-92.

PMID:
10383649
43.

Phylogenetically conserved CK-II phosphorylation site of the murine homeodomain protein Hoxb-6.

Fienberg AA, Nordstedt C, Belting HG, Czernik AJ, Nairn AC, Gandy S, Greengard P, Ruddle FH.

J Exp Zool. 1999 Apr 15;285(1):76-84.

PMID:
10327653
44.

Protein phosphatase 1 modulation of neostriatal AMPA channels: regulation by DARPP-32 and spinophilin.

Yan Z, Hsieh-Wilson L, Feng J, Tomizawa K, Allen PB, Fienberg AA, Nairn AC, Greengard P.

Nat Neurosci. 1999 Jan;2(1):13-7.

PMID:
10195174
45.

Neuronal and behavioural abnormalities in striatal function in DARPP-32-mutant mice.

Hiroi N, Fienberg AA, Haile CN, Alburges M, Hanson GR, Greengard P, Nestler EJ.

Eur J Neurosci. 1999 Mar;11(3):1114-8.

PMID:
10103106
47.

DARPP-32: regulator of the efficacy of dopaminergic neurotransmission.

Fienberg AA, Hiroi N, Mermelstein PG, Song W, Snyder GL, Nishi A, Cheramy A, O'Callaghan JP, Miller DB, Cole DG, Corbett R, Haile CN, Cooper DC, Onn SP, Grace AA, Ouimet CC, White FJ, Hyman SE, Surmeier DJ, Girault J, Nestler EJ, Greengard P.

Science. 1998 Aug 7;281(5378):838-42.

48.

Homeo box genes in murine development.

Fienberg AA, Utset MF, Bogarad LD, Hart CP, Awgulewitsch A, Ferguson-Smith A, Fainsod A, Rabin M, Ruddle FH.

Curr Top Dev Biol. 1987;23:233-56. Review.

PMID:
2897895
49.

Developmental regulation of polyamine metabolism in growth and differentiation of carrot culture.

Fienberg AA, Choi JH, Lubich WP, Sung ZR.

Planta. 1984 Dec;162(6):532-9. doi: 10.1007/BF00399919.

PMID:
24253270

Supplemental Content

Loading ...
Support Center